Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Prevention of Coronary Heart Disease”

146 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 146 results

Not applicableStudy completedNCT02478294
What this trial is testing

LAA Excision With AF Ablation Versus Oral Anticoagulants for Secondary Prevention of Stroke

Who this might be right for
Atrial FibrillationStrokeSystemic Embolism
The First Affiliated Hospital with Nanjing Medical University 474
Not applicableUnknownNCT03414190
What this trial is testing

Impact of Text Messages to Promote Secondary Prevention After Acute Coronary Syndrome

Who this might be right for
Cardiovascular Disease
Federal University of Minas Gerais 160
Not applicableStudy completedNCT00758810
What this trial is testing

Impact at One Year of a Secondary Prevention Educational Program on Cardiovascular Risk Factors

Who this might be right for
Myocardial InfarctionAcute Coronary Syndrome
Centre Hospitalier Universitaire de Saint Etienne 354
Not applicableLooking for participantsNCT06738381
What this trial is testing

Digital Secondary Prevention After Atherosclerotic Cardiovascular Disease

Who this might be right for
Atheroscleroses, CoronaryAtheroscleroses, CerebralAtherosclerotic Ischemic Disease
Vestre Viken Hospital Trust 300
Not applicableEnded earlyNCT05834673
What this trial is testing

VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN)

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)Coronary Heart Disease (CHD)Cerebrovascular Disease+1 more
Monash University 6
Not applicableStudy completedNCT02102503
What this trial is testing

Motivational Interviewing and Medication Review in Coronary Heart Disease

Who this might be right for
Coronary Heart Disease
Göran Petersson 417
Not applicableLooking for participantsNCT07031531
What this trial is testing

Effectiveness of an AI-Enabled Stratified Management System for Premature Coronary Artery Disease

Who this might be right for
Premature Coronary Heart Disease
China National Center for Cardiovascular Diseases 4,900
Not applicableUnknownNCT04781699
What this trial is testing

Optimising Secondary Prevention and Quality of Life in Early Cardiac Rehabilitation

Who this might be right for
Cardiovascular DiseasesCoronary Artery DiseaseMyocardial Infarction+3 more
Sheffield Hallam University 498
Testing effectiveness (Phase 2)Looking for participantsNCT05732051
What this trial is testing

Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients

Who this might be right for
Breast CancerMetastatic Breast CancerCancer Therapy-Related Cardiac Dysfunction+2 more
University Hospital, Akershus 60
Not applicableStudy completedNCT00536965
What this trial is testing

Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets

Who this might be right for
HyperlipidemiasAtherosclerosisCoronary Heart Disease+3 more
AstraZeneca 951
Large-scale testing (Phase 3)Not Yet RecruitingNCT07440381
What this trial is testing

TriPle Oral thERapy With Bempedoic Acid vs uSual Care in Early Lipid Management of Patients With acUte coronAry synDromE

Who this might be right for
Acute Coronary SyndromesSecondary PreventionLipids
Heart Care Foundation 600
Not applicableUnknownNCT05622292
What this trial is testing

The Effectivity of the Mobile App "HARKIT I-Care" in Secondary Prevention in Post-ACS Patients

Who this might be right for
Acute Coronary Syndrome
National Cardiovascular Center Harapan Kita Hospital Indonesia 60
Post-approval studies (Phase 4)Looking for participantsNCT05465031
What this trial is testing

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

Who this might be right for
Breast CancerNeoplasm, BreastBreast Diseases+10 more
Silesian Centre for Heart Diseases 600
Not applicableStudy completedNCT02617641
What this trial is testing

A Web-Based Tailored Nursing Intervention to Increase Walking in Patients After an Acute Coronary Syndrome

Who this might be right for
Acute Coronary Syndrome
Montreal Heart Institute 60
Post-approval studies (Phase 4)Study completedNCT02772640
What this trial is testing

Effectiveness of Treatment of Hypercholesterolemia With Rosuvastatin and Ezetimibe

Who this might be right for
Hypercholesterolemia
Collegium Medicum w Bydgoszczy 83
Testing effectiveness (Phase 2)Study completedNCT04158219
What this trial is testing

Healthy Heart Habits

Who this might be right for
Acute Coronary SyndromeDepression
Hennepin Healthcare Research Institute 8
Large-scale testing (Phase 3)Study completedNCT00617123
What this trial is testing

Trial to Assess the Ocular Safety of Vorapaxar (SCH 530348) in Participants With Atherosclerosis (Study P05183)

Who this might be right for
AtherosclerosisIschemiaMyocardial Infarction+1 more
Merck Sharp & Dohme LLC 258
Not applicableEnrolling By InvitationNCT04617639
What this trial is testing

The Norwegian Trial of Physical Exercise After Myocardial Infarction

Who this might be right for
Myocardial Infarction
Norwegian University of Science and Technology 9,700
Not applicableWithdrawnNCT04993664
What this trial is testing

Influence of Pelacarsen on Patients After Myocardial Infarction With High Lp(a) Values (PEMILA)

Who this might be right for
Acute Coronary SyndromeLipoproteinemiaInflammation+1 more
University Medical Centre Ljubljana
Not applicableStudy completedNCT07288502
What this trial is testing

Adherence to Secondary Prevention Drugs and Influencing Factors After Acute Coronary Syndrome in Patients at a Tertiary Center in Nepal

Who this might be right for
Acute Coronary Syndromes (ACS)Adherence
Institute of medicine, Maharagjung medical campus 109
Next Page